WMA Declaration of Helsinki – Ethical Principles f... ...
Drug candidate slows motor neuron disease progress...
NAD⁺ restores memory in Alzheimer's disease models...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Young adults commonly mix cannabis with nicotine and tobacco...
April 06,2026
You finally got a doctor's appointment. Here's how to get th...
April 05,2026
Thick melanoma tumors may be linked to poorer survival than ...
April 04,2026
Study demonstrates how pediatric integrative medicine can be...
April 03,2026
Sodium bicarbonate fails to boost survival in patients with ...
April 02,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Announcement of the 2025 Nobel Prize in ...
Can a twice-a-year shot help end the HIV...
Reprogramming Stem Cells Could Cure Type...
Dr. Fauci among hundreds who've contract...
More News
Promising results from phase 1 gene therapy trial for Danon disease

Promising results from phase 1 gene therapy trial for Danon disease

byChildren's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene the
Pediatrics November 22,2024
Promising results from phase 1 gene therapy trial for Danon disease

Promising results from phase 1 gene therapy trial for Danon disease

byChildren's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene the
Pediatrics November 22,2024
Scientists uncover new biallelic repeat expansion leading to mitochondrial encephalopathy

Scientists uncover new biallelic repeat expansion leading to mitochondrial encephalopathy

by Juntendo University Research Promotion CenterCredit:npj Genomic Medicine(2024). DOI: 10.1038/s41525-024-00429-5Mitochondrial diseases are among the most prevalent hereditary metabolic d
Neurology November 22,2024
Scientists uncover new biallelic repeat expansion leading to mitochondrial encephalopathy

Scientists uncover new biallelic repeat expansion leading to mitochondrial encephalopathy

by Juntendo University Research Promotion CenterCredit:npj Genomic Medicine(2024). DOI: 10.1038/s41525-024-00429-5Mitochondrial diseases are among the most prevalent hereditary metabolic d
Neurology November 22,2024
New drug targets for Alzheimer's identified from cerebrospinal fluid

New drug targets for Alzheimer's identified from cerebrospinal fluid

by Mark Reynolds,Washington University School of MedicineCellular localization of immune and lysosomal proteins. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01972-8A multit
Neurology November 22,2024
New drug targets for Alzheimer's identified from cerebrospinal fluid

New drug targets for Alzheimer's identified from cerebrospinal fluid

by Mark Reynolds,Washington University School of MedicineCellular localization of immune and lysosomal proteins. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01972-8A multit
Neurology November 22,2024
Molecular detection method tracks outbreak of drug-resistant fungi

Molecular detection method tracks outbreak of drug-resistant fungi

by Juliane Seeber,Friedrich Schiller University of JenaTimeline and hospital network dynamics of a Candida parapsilosis outbreak in Berlin, Germany. Credit:The Lancet Microbe(2024).
Public Health & Prevention November 22,2024
Molecular detection method tracks outbreak of drug-resistant fungi

Molecular detection method tracks outbreak of drug-resistant fungi

by Juliane Seeber,Friedrich Schiller University of JenaTimeline and hospital network dynamics of a Candida parapsilosis outbreak in Berlin, Germany. Credit:The Lancet Microbe(2024).
Public Health & Prevention November 22,2024
Genetic platform identifies 'Achilles heel' of drug-resistant Mycobacterium tuberculosis

Genetic platform identifies 'Achilles heel' of drug-resistant Mycobacterium tuberculosis

byUniversity of OtagoWG-CRISPRi screening in M. tuberculosis strain mc26206. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54072-wA University of Otago-led study has fo
Public Health & Prevention November 22,2024
Genetic platform identifies 'Achilles heel' of drug-resistant Mycobacterium tuberculosis

Genetic platform identifies 'Achilles heel' of drug-resistant Mycobacterium tuberculosis

byUniversity of OtagoWG-CRISPRi screening in M. tuberculosis strain mc26206. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54072-wA University of Otago-led study has fo
Public Health & Prevention November 22,2024
Scientists discover a rare missense variant in STAT6 that protects against asthma

Scientists discover a rare missense variant in STAT6 that protects against asthma

by deCODE geneticsp.L406P is a partial LOF variant. Credit:Journal of Allergy and Clinical Immunology(2024). DOI: 10.1016/j.jaci.2024.10.002Scientists at deCODE genetics and collaborators
Immunology & Rheumatology November 22,2024
Scientists discover a rare missense variant in STAT6 that protects against asthma

Scientists discover a rare missense variant in STAT6 that protects against asthma

by deCODE geneticsp.L406P is a partial LOF variant. Credit:Journal of Allergy and Clinical Immunology(2024). DOI: 10.1016/j.jaci.2024.10.002Scientists at deCODE genetics and collaborators
Immunology & Rheumatology November 22,2024
Discovery of new genes for molar pregnancies sheds light on their increased incidence in women aged 35 and over

Discovery of new genes for molar pregnancies sheds light on their increased incidence in women aged 35 and over

byMcGill UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170669A molar pregnancy, also known as a hydatidiform mole, is an abnormal huma
OB & GYN November 22,2024
Discovery of new genes for molar pregnancies sheds light on their increased incidence in women aged 35 and over

Discovery of new genes for molar pregnancies sheds light on their increased incidence in women aged 35 and over

byMcGill UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170669A molar pregnancy, also known as a hydatidiform mole, is an abnormal huma
OB & GYN November 22,2024
A new strategy to enhance gene therapy for sickle cell disease

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe
Oncology November 22,2024
A new strategy to enhance gene therapy for sickle cell disease

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe
Oncology November 22,2024
New resource maps gene-disease links across common conditions, paving the way for personalized medicine

New resource maps gene-disease links across common conditions, paving the way for personalized medicine

byHebrew University of JerusalemCredit: Pixabay/CC0 Public DomainA new study introduces an innovative tool for exploring gene-disease connections: the PWAS Hub. This resource is based on the nov
Breakthroughs November 22,2024
New resource maps gene-disease links across common conditions, paving the way for personalized medicine

New resource maps gene-disease links across common conditions, paving the way for personalized medicine

byHebrew University of JerusalemCredit: Pixabay/CC0 Public DomainA new study introduces an innovative tool for exploring gene-disease connections: the PWAS Hub. This resource is based on the nov
Breakthroughs November 22,2024
Huntington's disease gene may also enhance early brain development and intelligence

Huntington's disease gene may also enhance early brain development and intelligence

by Jennifer Brown,University of IowaYears-to-onset (YTO)-dependent brain functional changes. Credit:Annals of Neurology(2024). DOI: 10.1002/ana.27046The genetic mutation that causes
Neurology November 22,2024
Huntington's disease gene may also enhance early brain development and intelligence

Huntington's disease gene may also enhance early brain development and intelligence

by Jennifer Brown,University of IowaYears-to-onset (YTO)-dependent brain functional changes. Credit:Annals of Neurology(2024). DOI: 10.1002/ana.27046The genetic mutation that causes
Neurology November 22,2024
More News
Week’s Top
Podcasts
... Can AI Catch What Doctors Miss? ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Health spending has been rising across rich countries with different systems ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com